文献标题:Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial
影响因子:54.433
文献链接:The Lancet Oncology 21.2 (2020): 294-305;PMID: 31952975
研究单位:MD Anderson Cancer Center,美国MD安德森癌症中心
药企:Regeneron Pharmaceuticals